Interview | Leaders of London based LabGenius Therapeutics discuss a recent ESMO IO poster for their Nectin-4 x CD3 T-cell engager, and a new expanded collaboration with Sanofi on antibody optimisation
calendar_today
December 12, 2025
person
lucy
domainlabgenius